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Abstract
Background: The high fat, low carbohydrate ketogenic diet (KD) was developed as an alternative
to fasting for seizure management. While the mechanisms by which fasting and the KD inhibit
seizures remain speculative, alterations in brain energy metabolism are likely involved. We
previously showed that caloric restriction (CR) inhibits seizure susceptibility by reducing blood
glucose in the epileptic EL mouse, a natural model for human multifactorial idiopathic epilepsy. In
this study, we compared the antiepileptic and anticonvulsant efficacy of the KD with that of CR in
adult EL mice with active epilepsy. EL mice that experienced at least 15 recurrent complex partial
seizures were fed either a standard diet unrestricted (SD-UR) or restricted (SD-R), and either a
KD unrestricted (KD-UR) or restricted (KD-R). All mice were fasted for 14 hrs prior to diet
initiation. A new experimental design was used where each mouse in the diet-restricted groups
served as its own control to achieve a 20–23% body weight reduction. Seizure susceptibility, body
weights, and the levels of plasma glucose and β-hydroxybutyrate were measured once/week over
a nine-week treatment period.
Results: Body weights and blood glucose levels remained high over the testing period in the SD-
UR and the KD-UR groups, but were significantly (p < 0.001) reduced in the SD-R and KD-R
groups. Plasma β-hydroxybutyrate levels were significantly (p < 0.001) increased in the SD-R and
KD-R groups compared to their respective UR groups. Seizure susceptibility remained high in both
UR-fed groups throughout the study, but was significantly reduced after three weeks in both R-fed
groups.
Conclusions: The results indicate that seizure susceptibility in EL mice is dependent on plasma
glucose levels and that seizure control is more associated with the amount than with the origin of
dietary calories. Also, CR underlies the antiepileptic and anticonvulsant action of the KD in EL mice.
A transition from glucose to ketone bodies for energy is predicted to manage EL epileptic seizures
through multiple integrated changes of inhibitory and excitatory neural systems.
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Background
Epilepsy is a neurological disorder involving recurrent
abnormal discharges of neurons that produce epileptic
seizures [1]. With the exception of stroke, epilepsy is one
of the most prevalent human neurological afflictions
affecting about 1% of the US population [2,3]. Many per-
sons with epilepsy manifest partial or generalized seizures
without symptoms of brain abnormality, i.e., idiopathic
epilepsy [1,4,5]. In contrast to idiopathic epilepsy, symp-
tomatic or acquired epilepsy often accompanies brain
trauma, injury, or neurostructural defects. While some idi-
opathic epilepsies are inherited as simple Mendelian
traits, most are multifactorial where more than one gene
together with environmental factors contribute to the dis-
ease phenotype [6,7].
Epilepsy animal models are used widely to test the influ-
ence of environmental and genetic factors on seizure
mechanisms. The epileptic EL mouse is a natural model
for human multifactorial idiopathic epilepsy and was first
discovered in 1954 in an outbred DDY mouse colony
[6,8-10]. EL mice experience complex partial seizures with
secondary generalization similar to those seen in humans
[6,10]. Seizures in EL mice commence with the onset of
puberty (50–60 days), originate in or near the parietal
lobe, and then spread to the hippocampus and to other
brain regions [6,11-13]. The seizures are accompanied by
electroencephalographic abnormalities, vocalization,
incontinence, loss of postural equilibrium, excessive sali-
vation, and head, limb, and chewing automatisms
[10,12,14-17]. A reactive gliosis accompanies seizure pro-
gression in adult EL mice involving both astrocytes and
microglia [18,19]. Epileptic seizures in EL mice also
model Gowers' dictum, where each seizure increases the
likelihood of recurrent seizures [6]. Seizure susceptibility
can be managed with phenytoin and phenobarbital as
well as with diet therapies to include the ketogenic diet
and caloric restriction [20-22]. Gene-environmental inter-
actions play a significant role in the determination of sei-
zure frequency and onset in EL mice as with multifactorial
human idiopathic epilepsies [6,9,23].
Despite intensive antiepileptic drug (AED) research and
development, seizures remain unmanageable or refrac-
tory in many persons with epilepsy [24-26]. As an alterna-
tive to AEDs diet therapies can be effective in the
management or control of epilepsy. Fasting has long been
recognized as an effective antiepileptic therapy for a broad
range of seizure disorders [27-29]. Since fasting produces
ketonemia, it was originally thought that ketone bodies
(β-hydroxybutyrate and acetoacetate) might underlie the
antiepileptic effects of fasting [27,30]. Consequently, high
fat, low protein, low carbohydrate KDs were developed to
mimic the physiological effects of fasting [25,27,31,32].
Although the KD significantly elevates circulating ketone
body levels, later studies showed that ketone bodies alone
were unable to account for the antiepileptic and anticon-
vulsant effects of the KD in humans or in animal epilepsy
models [20,31,33-38]. Since the KD manages epilepsy
best when administered in restricted amounts and since
fasting lowers blood glucose levels, Seyfried and co-work-
ers suggested that caloric restriction might contribute to
the antiepileptic and anticonvulsant effects of the KD
[21,29,38].
CR is a natural dietary therapy that improves health,
extends longevity, and reduces the effects of neuroinflam-
matory diseases in rodents and humans [21,29,39,40]. CR
is produced from a total dietary restriction and differs
from acute fasting or starvation in that CR reduces total
caloric energy intake without causing anorexia or deficien-
cies of any specific nutrients [38]. In other words, CR
extends the health benefits of fasting while avoiding star-
vation. Besides improving health, CR has both antiepilep-
tic and anticonvulsant effects in EL mice and in other
animal epilepsy models [20,21,41]. A reduction in blood
glucose with a corresponding elevation in blood ketone
bodies is thought to underlie the antiepileptic and anti-
convulsant effects of CR [21,29,38].
Glucose uptake and metabolism increases more during
epileptic seizures than during most other brain activities
[42-44]. Blood glucose also positively correlates with
flurothyl-induced seizures in rats and high glucose may
exacerbate human seizure disorders [45]. Neuronal excit-
ability and epileptic seizures are directly related to rapid
glucose utilization and glycolysis [42,43,45-51]. It is not
yet clear, however, to what extent enhanced glycolysis is
related to the cause or effects of seizure activity [29]. Nev-
ertheless, a transition in brain energy metabolism from
glucose utilization to ketone body utilization reduces
neural excitation and increases neural inhibition through
multiple integrated systems [29,38]. Based on these and
other observations [50,52-54], we proposed that many
epilepsies, regardless of etiology, might ultimately involve
altered brain energy homeostasis [29].
In this study, we compared the antiepileptic and anticon-
vulsant effects of both the KD and CR in adult EL mice
that experienced at least 15 recurrent complex partial sei-
zures. The results show that seizure control in EL mice is
more associated with the amount than with the origin of
dietary calories, and that CR underlies the antiepileptic
and anticonvulsant action of the KD in EL mice. A prelim-
inary report of these findings was recently presented [55].
Results
Diet composition and tolerance
The composition of each diet is shown in Table 1 and in
the Methods. No adverse effects of the diets were observedNutrition & Metabolism 2004, 1:11 http://www.nutritionandmetabolism.com/content/1/1/11
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in either R-fed mouse group. Despite the 20–23% body
weight reduction, mice in both R-fed groups appeared
healthy and were more active than the mice in the UR-fed
groups as assessed by ambulatory and grooming behavior.
With the exception of oily fur, the KD-fed mice appeared
active and healthy throughout the study as previously
found [20]. No signs of vitamin or mineral deficiency
were observed in the R-fed mice according to standard cri-
teria for mice [56]. These findings are consistent with the
well-recognized health benefits of mild to moderate
caloric restriction in rodents [57], and support our previ-
ous findings that both the KD and a moderate CR are well
tolerated by EL mice [20,21].
Influence of caloric restriction on body weight
All mice were matched for age (approximately 210 days)
and body weight (approximately 31.0 ± 1.5 g) before the
start of the dietary treatment (Fig. 1). All mice lost approx-
imately 7–9% of their body weight during the 14 hr fast.
Body weight remained relatively stable over the nine-week
treatment period in both UR-fed mouse groups (Fig. 1).
The 20–23% body weight reduction was achieved in the
Table 1: Composition (%) of the Standard Diet and the Ketogenic Diet 1
Components Standard Diet (SD) Ketogenic Diet (KD)
Carbohydrate 62 0
Fat 6 75
Protein 27 14
Fiber 5 12
Energy (Kcal/gr) 4.4 7.8
1 According to manufacturer's specifications (see Methods).
Influence of diet on body weight in adult EL mice fed the SD (A) or the KD (B) Figure 1
Influence of diet on body weight in adult EL mice fed the SD (A) or the KD (B). Squares represent the pre-trial 
period when all mice were fed the SD-UR. Circles and triangles represent the UR-fed and R-fed groups, respectively. Values 
are expressed as the mean ± SEM (n = 6 mice per group). Arrow indicates initiation of CR.Nutrition & Metabolism 2004, 1:11 http://www.nutritionandmetabolism.com/content/1/1/11
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R-fed groups after about two weeks of gradual food restric-
tion. However, more difficulty was encountered initially
in maintaining a stable body weight reduction for the KD-
R group than for the SD-R group. This difficulty may result
from the high caloric content of the KD that produces
greater body weight changes per calorie adjustment than
the SD. We also estimated that the degree of CR necessary
to maintain the 20–23% body weight reduction was
about 38–45% for the SD and about 45–52% for the KD.
Influence of diets on seizure susceptibility in adult EL mice
All mice had at least 15 recurrent seizures before the start
of dietary treatment (arrow, Fig. 1). The seizures occurred
occasionally during routine cage changing prior to the
pre-trial period and regularly from handling during the
pre-trial test period. Seizure susceptibility was analyzed in
all mouse groups after the R-fed mice achieved a stable
body weight reduction, i.e., week five of treatment (Figs. 1
and 2). Seizure susceptibility was high for both UR-fed
groups throughout the study. In both R-fed groups, sei-
zure susceptibility decreased from 1.0 to about 0.3 after
two weeks and remained significantly lower than that of
the UR-fed control groups from treatment weeks 5–12
(Fig. 2). Only a single mouse in the KD-R group had a
break-through seizure on week 8. Taken together, our
findings show that seizure management in EL mice is
more associated with the amount than with the origin of
dietary calories.
Influence of diets on plasma glucose and β-
hydroxybutyrate levels
Plasma glucose levels were analyzed in all mouse groups
after the R-fed mice achieved a stable body weight reduc-
tion (Figs. 1 and 3). Glucose levels remained high for both
UR-fed groups throughout the study and were stable over
treatment weeks 5–12. However, plasma glucose levels
were somewhat lower (about 8 mM) in both UR-fed
groups between treatment weeks 3–5 compared to the
pre-trial glucose levels (about 10 mM). This reduction
might result from a combination of repetitive handling,
seizures, blood collection, and the initial fast. In both R-
fed mouse groups, the plasma glucose levels decreased
from about 10 mM to about 5.0 mM after three weeks and
remained significantly lower than those of their respective
UR-fed control groups (Fig. 3).
Plasma β-hydroxybutyrate levels were also analyzed in all
mouse groups after the R-fed mice achieved a stable body
weight reduction (Figs. 1 and 4). These levels remained
low in the SD-UR group throughout the study and were
stable for treatment weeks 5–12. β-hydroxybutyrate levels
were significantly higher in the R-fed groups than in their
respective UR-fed control groups (Fig. 4). These levels
were also significantly higher in the KD-UR group than in
the SD-UR group. The levels increased from about 0.4 mM
to about 1.7 mM in the SD-R group and to about 3.0 mM
in the KD-R group. These findings demonstrate that circu-
lating β-hydroxybutyrate levels were inversely related to
circulating glucose levels and that elevated β-hydroxybu-
Influence of diet on seizure susceptibility in adult EL mice Figure 2
Influence of diet on seizure susceptibility in adult EL 
mice. Asterisks indicate that seizure susceptibility was signif-
icantly lower (p < 0.001) in the R-fed groups than in their 
respective UR-fed groups. Values were pooled from treat-
ment weeks 5–12 (see Fig. 1) and are expressed as the mean 
± SEM (n = 6 mice per group).
Influence of diet on plasma glucose levels in adult EL mice Figure 3
Influence of diet on plasma glucose levels in adult EL 
mice. Asterisks indicate that the plasma glucose levels were 
significantly lower (p < 0.001) in the R-fed groups than in 
their respective UR-fed groups. Other conditions are as in 
Figures 1 and 2.Nutrition & Metabolism 2004, 1:11 http://www.nutritionandmetabolism.com/content/1/1/11
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tyrate levels alone are not associated with seizure
susceptibility.
Statistical relationships among variables
The relationship between body weight, food intake,
plasma glucose levels, plasma β-hydroxybutyrate levels,
and seizure susceptibility was determined using Pearson
bivariate correlation analysis (Table 2). All variables were
significantly (p < 0.01) correlated with each other. Posi-
tive correlations were found among body weight, food
intake, glucose, and seizure susceptibility. On the other
hand, β-hydroxybutyrate was negatively correlated with
all variables. The correlations among glucose, β-hydroxy-
butyrate, and seizure susceptibility were also apparent
from the data in Figures 2,3,4. Plasma glucose was signif-
icantly (p < 0.001) associated with seizure susceptibility
in the EL mouse, as determined by chi-square analysis
(Fig. 5). These results support our previous findings that
glucose levels are predictive of seizure susceptibility in
adult EL mice [21,29].
Binary logistic regression was also used to determine the
relationship between seizure susceptibility, plasma glu-
cose, and plasma β-hydroxybutyrate levels when mice
were fed either the SD and/or the KD. The data indicate
that regardless of diet, glucose could predict seizure
susceptibility with an approximate 75 to 78 % accuracy
(Table 3). Although β-hydroxybutyrate could also predict
seizure susceptibility, we previously showed that β-
hydroxybutyrate levels were dependent on and were
inversely related to plasma glucose levels [21].
Discussion
We found that restriction of either a high carbohydrate
low fat standard diet or a high fat low carbohydrate KD
was equally effective in reducing seizure susceptibility in
adult EL mice with active epilepsy. Moreover, seizure sus-
ceptibility remained similarly high in these mice when
either diet was fed ad libitum or unrestricted. These find-
ings indicate that the KD, when fed unrestricted, is unable
to reduce seizure susceptibility in adult EL mice. Although
the KD delays epileptogenesis in young seizure naïve EL
mice when fed ad libitum, the effect is transient [20]. These
findings are interesting since previous observations with
children suggest that the antiepileptic and anticonvulsant
effects of the KD are best when the diet is administered in
restricted amounts [25,31]. Indeed, seizure protection is
often less in children that gain weight than in those who
maintain or reduce body weight on the KD (Freeman, per-
sonal communication). Previous studies also indicate that
Influence of diet on plasma β-hydroxybutyrate levels in adult  EL mice Figure 4
Influence of diet on plasma β-hydroxybutyrate levels 
in adult EL mice. Asterisks indicate that the plasma β-
hydroxybutyrate levels were significantly higher (p < 0.001) 
in the R-fed groups than in their respective UR-fed groups. 
The cross indicates that the plasma β-hydroxybutyrate levels 
were significantly higher (p < 0.001) in the KD-UR group 
than in the SD-UR group. Other conditions are as in Figures 
1 and 2.
Association of plasma glucose and seizure susceptibility in  adult EL mice Figure 5
Association of plasma glucose and seizure suscepti-
bility in adult EL mice. Data were obtained from all four 
dietary groups over treatment weeks 3–12 for a total of 234 
seizure and glucose measurements. Seizure frequency in the 
three plasma glucose groups (< 6.5 mmol, 6.5–8.5 mmol, and 
> 8.5 mmol/L) was 8/234, 44/234, and 70/234, respectively. 
The association between glucose and seizure susceptibility 
was highly significant as determined by Chi-square analysis (p 
< 0.001).Nutrition & Metabolism 2004, 1:11 http://www.nutritionandmetabolism.com/content/1/1/11
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restriction of high carbohydrate diets elevate seizure
threshold [58]. Our findings in EL mice support these
observations and suggest that CR may be necessary for the
antiepileptic and anticonvulsant effects of the KD.
We previously showed that mild to moderate CR delayed
epileptogenesis and reduced seizure susceptibility in
seizure naïve juvenile and adult EL mice by reducing
blood glucose and elevating ketone bodies [21]. Although
our data show that circulating β-hydroxybutyrate levels
are inversely related to circulating glucose levels, elevated
ketone body levels are not directly associated with
reduced seizure susceptibility in EL mice. This conclusion
derives from the finding that seizure susceptibility is high
in the KD-UR mice despite elevated β-hydroxybutyrate
levels and from finding that seizure protection was similar
in the SD-R and KD-R groups despite significantly higher
β-hydroxybutyrate levels in the KD-R than in the SD-R
group. These results are consistent with previous studies
in EL mice and in non-genetic seizure models that ele-
vated ketone bodies alone are unable to account for the
antiepileptic or anticonvulsant action of the KD
[20,31,33-38].
Under normal physiological conditions brain cells derive
most of their energy from glucose or glucose-derived
metabolites, e.g., lactate [46,59,60]. Also, brain glucose
uptake is greater during epileptic seizures than during
most other brain activities [43]. During fasting or caloric
restriction, however, circulating glucose levels fall causing
brain cells to rely more heavily for energy on ketone bod-
ies that gradually increase with food restriction [29,61]. It
is the transition from glucose to ketone bodies for brain
energy that is thought to underlie the antiepileptic and
Table 2: Pearson bivariate correlation of body weight, food intake, plasma glucose levels, plasma b-hydroxybutyrate levels, and seizure 
susceptibility in adult EL mice 1
Parameter Body weight (g) Food Intake (Kcal) Glucose (mM) Ketones (mM) Seizure 
Susceptibility
Body weight (g) 1.000
Food Intake (Kcal) 0.488* 1.000
Glucose (mM) 0.509* 0.382* 1.000
Ketones (mM) -0.379* -0.379* -0.429* 1.000
Seizure Susceptibility 0.512* 0.464* 0.616* -0.510* 1.000
1 Data were obtained from all four dietary groups over the treatment weeks 3–12 for a total number of 210 seizure and glucose measurements (see 
figure 1).
* All correlations were significant at the 0.01 level (2-tailed).
Table 3: Binary logistic regression analysis of the maximum likelihood estimates between plasma glucose, and seizure susceptibility in 
adult EL mice fed either the SD or KD1
Dietary groups Parameter Df2 B3 SEM4 Wald x2 5 p value6
SD Glucose 1 0.774 0.139 30.962 0.01
Constant 1 -0.584 1.013 29.292 0.01
KD Glucose 1 0.787 0.157 25.033 0.01
Constant 1 -5.801 1.180 24.177 0.01
Both Diets Glucose 1 0.752 0.102 54.682 0.01
Constant 1 -5.507 0.759 52.625 0.01
1 Data were obtained from all four dietary groups over the treatment weeks 3–12 for a total number of 210 individual measurements of plasma 
glucose and seizure susceptibility.
2 Df, degrees of freedom.
3 B, Estimate of the association between glucose and seizure susceptibility.
4 The estimated error of the mathematical weighting, indicating the precision of the estimated coefficient.
5 The Wald test statistic was computed from the data compared by using x2 distribution with 1 degree of freedom. The test statistic is used to 
determine the p value.
6 The probability of Type I error.Nutrition & Metabolism 2004, 1:11 http://www.nutritionandmetabolism.com/content/1/1/11
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anticonvulsant effects of caloric restriction [29]. Although
the KD we used contained no carbohydrates, the mice eat-
ing this diet maintained high glucose levels and seizure
susceptibility. The persistence of high glucose levels in the
KD-UR group would prevent the transition to ketones for
energy despite high levels of circulating ketone bodies.
Our results show that circulating glucose levels accurately
predict seizure susceptibility in EL mice regardless of diet
composition or circulating ketone body levels.
We used a new experimental design for caloric restriction
in this study. Instead of restricting calories in the R-fed
mice based on the average food consumption of the UR
control mice as we did previously [21], each R-fed mouse
served as its own control to achieve and maintain a 20–
23% body weight reduction. We found in a pilot study
that isocaloric restriction of the KD was unable to reduce
body weight to the same degree as that observed for a sim-
ilar restriction of the SD. The new experimental design
reduces variability in body weights and in caloric intake
among mice fed diets widely different in nutritional com-
position and caloric content. In using body weight, rather
than caloric intake, as an independent variable we were
able to more accurately measure the statistical associa-
tions among circulating energy metabolites and seizure
susceptibility. Thus, this type of experimental design is
recommended for those studies attempting to evaluate the
relationships among nutrition, metabolism, and disease
phenotype.
We previously discussed the potential mechanisms by
which CR might reduce seizure susceptibility [21,29,38].
Some of the cellular systems potentially modulated
through CR that could influence brain excitability are
illustrated in Fig. 6. We suggest that the transition from
glucose to ketone bodies as a major energy fuel for the
brain produces multiple changes in gene-linked meta-
bolic networks. It is these changes that gradually adjust
neurotransmitter pools and membrane excitability to
restore the physiological balance of excitation and inhibi-
tion [29]. CR could also influence seizure susceptibility
through the neuroendocrine system involving leptin sign-
aling and increased levels of neuropeptide-Y, a peptide
with antiepileptic and anticonvulsant effects [62-65].
While the levels of γ-aminobutyric acid (GABA) are
increased in synaptosomes via the increased action of
glutamic acid decarboxylase during the metabolism of
ketone bodies for energy, the levels of aspartate decrease
due to the formation of glutamate [66]. In addition,
ketone body metabolism could increase membrane ionic
pump activity [67,68]. Increased pump activity could
increase membrane potential in neurons while also
increasing neurotransmitter uptake in glia [29]. We do not
exclude the possibility that CR may reduce seizure
susceptibility in EL mice through additional mechanisms
[31,69]. It is our contention that CR reduces seizure
susceptibility through multiple integrated systems provid-
ing a multifactorial therapy to a multifactorial disease.
Further studies in the EL mouse and in other epilepsy
models are needed to identify the exact mechanisms of CR
action in managing epileptic events.
Conclusions
We conclude that seizure susceptibility in EL mice is
dependent on plasma glucose levels and that seizure con-
trol depends more on the amount than on the origin of
dietary calories. Also, we found that CR underlies the
antiepileptic action of the KD in EL mice. A transition
from glucose to ketone bodies for energy is predicted to
manage EL epileptic seizures through multiple integrated
changes of inhibitory and excitatory neural systems.
Methods
Mice
The inbred EL/Suz (EL) mice were originally obtained
from J. Suzuki (Tokyo Institute of Psychiatry). The mice
were maintained in the Boston College Animal Care Facil-
ity as an inbred strain by brother × sister mating. The mice
were group housed (prior to initiation of study) in plastic
cages with Sani-chip bedding (P.J. Murphy Forest
Products Corp., Montville, N.J.) and kept on a 12-hr light/
dark cycle at approximately 22°C. Cotton nesting pads
were provided for warmth when animals were individu-
ally housed. All cages and water bottles were changed
once per week. Only females were used for these studies as
adult males die sporadically with age from acute uremia
poisoning due to urinary retention [70]. The procedures
for animal use were in strict accordance with the NIH
Guide for the Care and Use of Laboratory Animals and
were approved by the Institutional Animal Care
Committee.
Seizure Susceptibility and Seizure Testing
Seizure onset in EL mice is generally between 60–70 days
of age as previously described [6]. These seizures occur
occasionally during routine cage changing. Our recently
developed seizure handling protocol was used to regularly
induce seizure susceptibility in EL mice [6,21]. Briefly, the
testing procedure included repetitive handling and simu-
lated the stress normally associated with weekly cage
changing, i.e., picking the mouse up by the tail for short
intervals and transferring it to a clean cage with fresh bed-
ding. The test included two trials that were separated by
30 min. In each trial, a single mouse was held by the tail
for 30 sec at approximately 10–15 cm above the bedding
of its home cage. After 30 sec, the mouse was placed into
a clean cage with fresh bedding for 2 min. The mouse was
then held again for 15 sec before being returned to its
home cage. Trial 2 was performed even if the mouse expe-
rienced a seizure in trial 1. The epileptic seizures com-Nutrition & Metabolism 2004, 1:11 http://www.nutritionandmetabolism.com/content/1/1/11
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menced during holding or soon after the mice were placed
on the clean bedding. Mice that developed an epileptic
seizure while handling were placed immediately in either
the clean cage or their home cage depending on the testing
stage. Mice were tested each week for a total of 13
measurements over a 12-week period using this method.
Mice were undisturbed between testing phases (no cage
changing) and testing was performed between 12 to 3 pm.
Seizure Phenotype
Mice were designated seizure susceptible if they experi-
enced a generalized seizure during seizure testing. Gener-
alized seizures in EL mice involve loss of postural
equilibrium and consciousness, together with excessive
salivation, head, limb, and chewing/swallowing
automatisms. An erect forward-arching Straub tail, indic-
ative of spinal cord activation, was also seen in most mice
having generalized seizures. Mice that displayed only
vocalization and twitching without progression to gener-
alized seizure were not considered seizure susceptible
[6,21]. Seizure susceptibility scores were generated for
each mouse according to the seizure severity scores previ-
ously described [6]. Mice having a score of 4 or 5 were
assigned a susceptibility score of 1.0, whereas mice having
Perspectives on the metabolic management of epilepsy through a dietary reduction of glucose and elevation of ketone bodies Figure 6
Perspectives on the metabolic management of epilepsy through a dietary reduction of glucose and elevation of 
ketone bodies. A dietary reduction in blood glucose levels will increase ketone utilization for energy. This is expected to shift 
the neural environment from excitation to inhibition through multiple integrated systems. Abbreviations: GLUT-1 (glucose 
transporter), MCT (monocarboxylate transporter), PFK (phosphofructokinase), PDH (pyruvate dehydrogenase), SCOT (succi-
nyl-CoA-acetoacetate-CoA transferase), β-OHB (β-hydroxybutyrate), β-HBDH (β-hydroxybutyrate dehydrogenase), NPY 
(Neuropeptide Y), GABA (gamma-aminobutyric acid). Modified from Seyfried et al., 2004 [38].
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a seizure severity score less than 4 were given a susceptibil-
ity score of 0. The seizure susceptibility for each mouse
was then averaged over multiple tests and the mean sei-
zure susceptibility for a mouse dietary group was
determined.
Diets
All mice received PROLAB RMH3000 chow diet (LabDiet,
Richmond, IN, USA) prior to the experiment. This is the
standard food pellet diet (SD) and contained a balance of
mouse nutritional ingredients. According to the manufac-
turer's specification, this diet delivers 4.4 Kcal/g gross
energy, where fat, carbohydrate, protein, and fiber com-
prised 55 g, 520 g, 225 g, and 45 g/Kg of the diet, respec-
tively. The ketogenic diet (KD) was obtained from the
Zeigler Bros., Inc. (Gardners, PA, USA) in butter-like form
and also contained a balance of mouse nutritional ingre-
dients. According to the manufacturer's specification, the
KD delivers 7.8 Kcal/g gross energy, where fat,
carbohydrate, protein, and fiber comprised 700 g, 0 g, 128
g, and 109 g/Kg of the diet, respectively. The fat in this diet
was derived from lard and the diet had a ketogenic ratio
(fats: proteins + carbohydrates) of 5.48:1. The individual
% composition of each dietary energy component for the
SD and KD diet is shown on Table 1.
Pre-Trial Period
Seizure susceptibility, body weight, and food intake was
measured four times over a three-week period in 24 singly
caged female EL mice (approximately 210 days of age). All
mice received the SD during the pre-trial period and food
intake was determined by subtracting the weight of food
pellets remaining in the food hopper after one week from
the initial amount given (200 g). The difference was then
divided by seven to estimate the average daily food intake.
Thus, all mice were highly seizure susceptible at the initi-
ation of the diet therapy.
Dietary Treatment
After the three-week pre-trial period, the mice were placed
into four groups (n = 6 mice/group) where the average
body weight of each group was similar (about 31.0 ± 1.5
g) (Fig. 1). All mice were then fasted for 14 hr to establish
a similar metabolic set point at the start of the experiment
(arrow, Fig. 1). The mice in each group were then given
one of four diets to include: 1) the standard diet fed ad
libitum or unrestricted (SD-UR), 2) the KD fed ad libitum
or unrestricted (KD-UR), 3) the SD restricted to achieve a
20–23% body weight reduction from the pre-trial weight
(SD-R), and 4) the KD restricted to achieve a 20–23%
body weight reduction from the pre-trial weight (KD-R).
Each mouse in the two R groups served as its own control
for body weight reduction. Based on food intake and body
weight during the pre-trial period, food in the R-fed
mouse groups was reduced until each mouse achieved the
target weight reduction of a 20–23%. In other words, the
daily amount of food given to each R mouse was reduced
gradually until it reached 77–80% of its initial (pre-trial)
body weight.
The mice in the SD-UR group received 200 g of food in the
hopper/week as in the pre-trial period. For mice in the SD-
R group, weighed food pellets were dropped directly into
each cage for easy access. The KD was administered to the
mice in a modified plastic Falcon tissue culture dish (60
mm × 15 mm). The dish edges were shaved to reduce the
height from 15 mm to about 6 mm. After placing about 5
g of KD in the dish for the KD-UR mice, the dish with the
weighed KD was inverted and placed on the top of the
food hopper. An empty water bottle was placed on top of
the dish to prevent dish movement during animal feed-
ing. The butter-like consistency adhered the KD to the
inverted dish. This feeding apparatus allowed the mice
easy access to the KD and prevented KD contact with bed-
ding material. After about 24 hr, the amount of KD con-
sumed was determined and another 5 grams of fresh KD
were added to the dish. The KD was therefore given fresh
every day without moving or disturbing the mice. The
total amount of KD consumed per day was summed each
week and divided by 7 to obtain the average weekly food
intake of each mouse. For the KD-R mice, a calculated
restricted amount of KD was placed directly on top of the
food hopper bars for easy access. The R-fed mice licked the
bars clean of the KD.
Measurement of plasma glucose and β-hydroxybutyrate
Blood was collected approximately 1 h after seizure test-
ing except for the pre-trial period where blood was not
collected. Blood was first collected from all mice about 24
hr prior to the initiation of the 14 hr fast (Fig. 1). Mice
were anesthetized with isoflurane, USP (Halocarbon,
River Edge, NJ, USA) and blood was collected in
heparinized tubes by puncture of the retro-orbital sinus
using a borosilated capillary tube (FHC, Bowdoinham,
ME, USA). The blood was centrifuged at 6,000 × g for 10
min, the plasma was collected, and aliquots were stored at
-80°C until analysis. Plasma glucose concentration was
measured spectrophotometrically using the Trinder Assay
(Sigma-Aldrich, St. Louis, MO, USA). Plasma β-hydroxy-
butyrate concentration was measured using either the
Stanbio  β-Hydroxybutyrate LiquiColor®  procedure
(Stanbio, Boerne, TX, USA), or a modification of the Wil-
liamson et al procedure [71].
Statistical Analysis
Both ANOVA and a two-tailed t test were used to evaluate
the significance of differences of body weight, seizure
susceptibility, plasma glucose levels, and plasma β-
hydroxybutyrate levels between unrestricted and restricted
groups. Chi-square analysis was performed on the associ-Nutrition & Metabolism 2004, 1:11 http://www.nutritionandmetabolism.com/content/1/1/11
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ation between glucose and seizures. Pearson bivariate cor-
relation analysis (SPSS software) was used to determine
the relationship between body weight, food intake,
plasma glucose levels, plasma β-hydroxybutyrate levels,
and seizure susceptibility. Binary logistic regression
(SPSS) was used to determine the relationship between
seizure susceptibility, plasma glucose, and β-hydroxybu-
tyrate levels on mice fed either the SD or the KD. Differ-
ences were considered significant at p < 0.01. All values
are expressed as mean ± SEM. All statistical data were pre-
sented according to the recommendations of Lang et al.,
[72].
Lists of abbreviations
AED, antiepileptic drug; CR, caloric restriction; KD,
ketogenic diet; R, restricted; SD, standard diet; UR,
unrestricted.
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